OOIR: Observatory of International Research

Papers

(The TQCC of Paediatric Respiratory Reviews is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
A systematic cochrane review of corrector therapies (with or without potentiators) for people with cystic fibrosis with class II gene variants (most commonly F508DEL)	152
Impact of prenatal and early life environmental exposures on normal human development	32
Does machine learning have a role in the prediction of asthma in children?	25
Narrative review of clinical prediction models for paediatric community acquired pneumonia	21
Regional oxygenation, perfusion and body and/or head position: Are preterm infants adversely impacted? A systematic review	21
Comparison of video laryngoscopy and direct laryngoscopy for urgent intubation in newborn infants: A meta-analysis	20
Post viral bronchiolitis obliterans in children: A rare and potentially devastating disease	18
Investigation of neutrophil/lymphocyte ratio and mean platelet volume in patients diagnosed with preterm labor	17
Socioeconomic determinants of outcomes in childhood asthma	17
Addition of long‐acting beta‐agonists to inhaled corticosteroids for asthma in preschool children: A systematic review	16
Complicated intrathoracic tuberculosis: Role of therapeutic interventional bronchoscopy	16
The interplay between airway epithelium and the immune system – A primer for the respiratory clinician	16
Characterising the lifelong consequences of bronchopulmonary dysplasia	16
Learning from cystic fibrosis: How can we start to personalise treatment of Children’s Interstitial Lung Disease (chILD)?	15
The management of upper airway obstruction in Pierre Robin Sequence	14
The ethics of publishing in medical journals	13
Approaches to the management of haemoptysis in young people with cystic fibrosis	13
Cough medicines for children- time for a reality check	12
A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis	11
Issues affecting young people with asthma through the transition period to adult care	10
Microbiology and management of respiratory infections in children with tracheostomy	9
Covid-19 and the impact on young athletes	8
Exercise capacity and the psychosocial effect in preterm born infants – Should we do more?	8
Editorial Board	8
Sudden Unexpected Death in Infancy [SUDI]: What the clinician, pathologist, coroner and researchers want to know	8

Respiratory infections in low and middle-income countries	8
Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections	7
Post-tuberculosis lung disease in children and adolescents: A scoping review of definitions, measuring tools, and research gaps	7
Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments	6
Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology	6
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps	6
What we have learnt about trauma, loss and grief for children in response to COVID-19	6
Towards standardized and clinically relevant definitions of hypoxemia and hyperoxemia in preterm infants: A systematic review	6
Face masks and protection against COVID-19 and other viral respiratory infections: Assessment of benefits and harms in children	5
Necrotizing Pneumonia In Children: A Review	5
A review of imaging in the diagnosis and management of complicated paediatric pneumonia	5
Weaving ethics into our activities	5
Non-invasive respiratory support in preterm infants	5
Health disparities in pediatric sleep-disordered breathing	5
Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development	5
Racial and skin color mediated disparities in pulse oximetry in infants and young children	5
Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience	5
Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses	4
Physical activity and exercise training in cystic fibrosis	4
Applying lessons learnt from research of child pneumonia management in Vietnam	4
Exercise testing for young athletes	4
Diagnostic and interventional paediatric bronchoscopy in low and middle-income countries	4
Thoracic insufficiency syndrome: Approaches to assessment and management	4
Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management	4
Editorial Board	4
The potential effects of climate change on non-cystic fibrosis bronchiectasis in children	4
A review of post COVID syndrome pathophysiology, clinical presentation and management in children and young people	4
Gaming the future	4
Cheyne-stokes respiration in children with heart failure	4
Race, bias, disparities, and pulmonary medicine	4
In modulators we trust	4
Should an inhaled corticosteroid accompany each dose of fast-acting beta2-agonist for relief of asthma symptoms?	4